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subsequently treated with tumour necrosis factor-a (TNF-a) in combina-
tion with Actinomycin D to induce apoptosis. Apoptotic chondrocytes in
cartilage sections were identiﬁed using an indirect immunohistochemical
staining technique to detect expression of active caspase-3. Haematoxylin
and eosin/safranin-o stained sections were used to score cellularity and
structural differences between samples.
Results: Prior to culture, (mean±standard deviation) chondrocyte via-
bility was 80.7% (3.5). The extent of chondrocyte apoptosis induced
by TNF-a/Actinomycin D varied markedly according to the joint type
that the cartilage was sampled from. For MCP joints, the extent of
overall chondrocyte apoptosis was signiﬁcantly higher (P< 0.001) in TNF-
a/Actinomycin D-stimulated explants (26.7%, 10.3) than that observed in
unstimulated control samples (9.6%, 7.5). Chondrocytes from PIP and
DIP joint cartilage did not respond signiﬁcantly to apoptotic stimulation
(P> 0.05); apoptosis in both control and stimulated explants was virtually
identical. Signiﬁcant variations in cellularity and thickness were evident
between cartilages of different joint types. Cartilage from DIP and PIP
joints was signiﬁcantly thicker than that of the MCP joint (P< 0.001 and
P< 0.05 respectively). Moreover, MCP joint AC was signiﬁcantly more
cellular than both PIP and DIP joints (P< 0.001).
Conclusions: Data in this study demonstrate that chondrocytes from
three equine joint types with varying prevalence’s of OA differ signiﬁcantly
in terms of susceptibility to apoptosis induction. This may provide a
possible explanation for the joint-speciﬁc nature of the disease. Joint-
type dependent differences in cartilage thickness and cellularity may also
have contributory roles.
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Purpose: The production of reactive oxygen species and inﬂammatory
mediators may contribute to the disregulation of cartilage homeostasis
in osteoarthritis (OA). We have shown recently the protective effects
of the CO-releasing molecule (CO-RM) tricarbonyldichlororuthenium (II)
dimer (CORM-2) against OA cartilage degradation, with down-regulation
of catabolic enzymes and enhancement of glycosaminoglycan synthesis.
The objective of the present study was to investigate whether CORM-2
is able to inhibit the production of oxidative stress and the inﬂammatory
response induced by interleukin 1b (Il-1b) in primary human OA chondro-
cytes.
Methods: Cartilage specimens were obtained from 17 patients with
diagnosis of advanced OA undergoing total knee joint replacement.
Chondrocytes were isolated by digestion with collagenase and used in
primary culture. Cells were stimulated with Il-1b (100U/ml) for different
times in the presence or absence of CORM-2 (50, 100 or 150 mM). Protein
expression was investigated by Western blot and immunoﬂuorescence.
Cytokine levels were determined by ELISA and prostaglandin E2 (PGE2)
by RIA. Gene expression was measured by real-time quantitative PCR.
Oxidative stress was assessed by laser scanning cytometry analysis.
Nuclear factor-úB (NF-úB) and hypoxia inducible factor-1a (HIF-1a) DNA
binding was quantitated by ELISA in nuclear extracts.
Results: CORM-2 signiﬁcantly decreased Il-1b-stimulated reactive oxy-
gen species production in OA chondrocytes. The inhibition of oxidative
stress was related to the down-regulation of gp91-phox. In addition,
CORM-2 inhibited tumor necrosis factor-a levels but enhanced Il-1 re-
ceptor antagonist production. Our studies have shown that CORM-2 is
able to control the enhanced synthesis of PGE2 in OA chondrocytes
treated with Il-1b, which can be mainly dependent on the reduction
in microsomal PGE synthase-1 gene expression with minor effects on
cyclooxygenase-2. Il-1b strongly stimulated the binding of HIF-1a to its
consensus sequence, whereas in chondrocytes treated with CORM-2, a
concentration-dependent inhibition was observed. This agent also inhib-
ited NF-úB-DNA binding.
Conclusions: Results from the present study establish the presence of
antioxidative and antiinﬂammatory mechanisms in the beneﬁcial effects
elicited by CORM-2 in OA chondrocytes and cartilage. Our data suggest
that inhibition of NF-úB and HIF-1a activation may play a role in the
inhibitory effects of CORM-2 on the production of mediators relevant in
OA.
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Purpose: The objective of the study was to investigate the effects of
rosemary, an herb frequently used in Mediterranean cuisine, and of
carnosol, one of its main antioxidant, on cartilage degradation after
catabolic stimulation.
Methods: In a ﬁrst set of experiments (n = 3), S35-labelled bovine artic-
ular cartilage explants were cultured for 3 days with Il-b in the presence
or absence of various doses of rosemary extract or carnosol (50, 25,
10, 5mg/ml for both). Cell viability was assessed by the release of
lactate deshydrogenase. Glycosaminoglycan degradation was measured
by quantifying the amount of S35 released in the culture media. In
a second set of experiment (n = 1), bovine articular cartilage explants
were cultured for 21 days with oncostatin and TNF-a in the presence
or absence of various doses of rosemary extract (100, 50, 10 mg/ml) or
carnosol (3.31, 1.66, 0.33 mg/ml corresponding to 10, 5 and 1 mM). Cell
viability was assessed by the AlamarBlue assay. MMP mediated collagen
and glycosaminoglycan degradation were assessed by measuring the
amounts of CTX-II and 342FFGVG epitopes released in the culture media
over the 21 days of culture. Aggrecanase mediated aggrecan degradation
was assessed by measuring the amount of 374ARGSV epitope released
in the culture media over the 9 ﬁrst days of culture.
Results: In the ﬁrst set of experiments, rosemary extract, at doses rang-
ing from 50 down to 5mg/ml, and carnosol, at the doses of 10 and 5 mg/ml,
inhibited IL1-b induced S35 release without affecting cell viability. At the
highest doses of 50 and 25mg/ml, carnosol decreased cell viability. In
the second set of experiment, rosemary extract at the lowest tested dose
(10mg/ml) almost completely abolished the MMP mediated degradation
of aggrecan and of type II collagen induced by oncostatin and TNF-a
without affecting the aggreganase mediated aggrecan degradation. At
this low dose, rosemary extract did not affect cell viability contrary to
the 2 highest tested doses (50 and 100mg/ml). Conversely, the 2 lowest
tested doses of carnosol (1.66, 0.33mg/ml) decreased the aggrecanase
mediated aggrecan degradation witouth affecting the MMP mediated
degradation of aggrecan and type II collagen. The highest tested dose of
carnosol (3.31 g/ml) decreased cell viability.
Conclusions: Taken together, these results indicate that rosemary ex-
tract slow down cartilage degeneration in vitro by inhibiting MMP activity.
Preliminary observations suggest that the effects of rosemary extract on
cartilage degeneration are not solely mediated by its content in carnosol
since the anti-catabolic effect of carnosol and rosemary extract on articu-
lar cartilage only partly overlap. These ﬁndings provide a rationale basis
for the in vivo testing of rosemary extract in osteoarthritis.
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Purpose: Previous studies demonstrated the ability of Glucosamine
(GlcN) to inhibit mRNA transcription level of Interleukin-1b (Il-1b)-
stimulated genes. These genes are under the control of two transcription
factors Activator Protein (AP)-1 and NF-kB. The aim of this study was to
determine the effects of GlcN on mitogen-activated protein (MAP) kinase
phosphorylation and on activation of AP-1, in human chondrocytes.
Methods: Human immortalized cell line, lbpva55, and human chondro-
cytes, obtained from healthy donors, were challenged with 10 ng/ml Il-1b
cytokine after pre-treatment with 2.5 or 10mM GlcN. mRNA expression
levels of some matrix metalloprotease (MMP) genes were evaluated by
Quantitative-Real Time PCR (Q-RT-PCR), protein production levels were
evaluated in the culture supernatant by Enzyme Linked ImmunoSorbent
Assay (ELISA). MAP kinase phosphorylation was evaluated by Western
Blotting. AP-1 transcription factor activation was evaluated by measuring
AP-1 component DNA binding activity (TransAM AP-1 family kit).
Results: After Il-1b stimulation, MMP-1, -3 and -13 productions were
strongly increased both at mRNA and protein level. Treatment with GlcN
reduced the expression of these metalloproteases. MMP-1, -3 and -13
expression is regulated by transcription factors such as AP-1, which is ac-
tivated by phosphorylated MAP kinases. Il-1b stimulated phosphorylation
